Annual EBIT
-$37.87 M
-$5.92 M-18.53%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual earnings before interest & taxes is -$37.87 million, with the most recent change of -$5.92 million (-18.53%) on December 31, 2023.
- During the last 3 years, SLS annual EBIT has fallen by -$20.89 million (-122.99%).
- SLS annual EBIT is now -1474.59% below its all-time high of -$2.40 million, reached on December 31, 2006.
Performance
SLS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$7.33 M
+$292.00 K+3.83%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly earnings before interest & taxes is -$7.33 million, with the most recent change of +$292.00 thousand (+3.83%) on September 30, 2024.
- Over the past year, SLS quarterly EBIT has increased by +$848.00 thousand (+10.37%).
- SLS quarterly EBIT is now -183.82% below its all-time high of $8.74 million, reached on December 31, 2016.
Performance
SLS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$32.77 M
+$2.03 M+5.84%
September 30, 2024
Summary
- As of February 8, 2025, SLS TTM earnings before interest & taxes is -$32.77 million, with the most recent change of +$2.03 million (+5.84%) on September 30, 2024.
- Over the past year, SLS TTM EBIT has increased by +$5.10 million (+13.46%).
- SLS TTM EBIT is now -4178.33% below its all-time high of -$766.00 thousand, reached on December 31, 2006.
Performance
SLS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.5% | +10.4% | +13.5% |
| 3 y3 years | -123.0% | +19.0% | -21.7% |
| 5 y5 years | -75.8% | +19.0% | -21.7% |
SLS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -93.3% | at low | -1422.9% | +56.2% | -67.3% | +14.7% |
| 5 y | 5-year | -123.0% | at low | -1422.9% | +56.2% | -116.1% | +14.7% |
| alltime | all time | -1474.6% | +13.7% | -183.8% | +56.2% | -4178.3% | +31.6% |
SELLAS Life Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.33 M(-3.8%) | -$32.77 M(-5.8%) |
| Jun 2024 | - | -$7.62 M(-21.0%) | -$34.80 M(-3.9%) |
| Mar 2024 | - | -$9.64 M(+18.0%) | -$36.23 M(-4.3%) |
| Dec 2023 | -$37.87 M(+18.5%) | -$8.18 M(-12.6%) | -$37.87 M(+30.0%) |
| Sep 2023 | - | -$9.36 M(+3.4%) | -$29.14 M(+8.2%) |
| Jun 2023 | - | -$9.05 M(-19.8%) | -$26.92 M(+1.6%) |
| Mar 2023 | - | -$11.28 M(-2136.3%) | -$26.50 M(-17.1%) |
| Dec 2022 | -$31.95 M(+63.1%) | $554.00 K(-107.8%) | -$31.95 M(-16.8%) |
| Sep 2022 | - | -$7.15 M(-17.1%) | -$38.42 M(+0.4%) |
| Jun 2022 | - | -$8.62 M(-48.5%) | -$38.25 M(+12.2%) |
| Mar 2022 | - | -$16.73 M(+182.7%) | -$34.08 M(+74.0%) |
| Dec 2021 | -$19.59 M(+15.4%) | -$5.92 M(-15.2%) | -$19.59 M(+9.9%) |
| Sep 2021 | - | -$6.98 M(+56.7%) | -$17.83 M(+16.2%) |
| Jun 2021 | - | -$4.45 M(+98.4%) | -$15.35 M(+1.2%) |
| Mar 2021 | - | -$2.25 M(-46.0%) | -$15.16 M(-10.7%) |
| Dec 2020 | -$16.98 M(-1.3%) | -$4.16 M(-7.4%) | -$16.98 M(-2.8%) |
| Sep 2020 | - | -$4.49 M(+5.3%) | -$17.47 M(+1.8%) |
| Jun 2020 | - | -$4.27 M(+5.0%) | -$17.16 M(+1.5%) |
| Mar 2020 | - | -$4.06 M(-12.5%) | -$16.91 M(-1.7%) |
| Dec 2019 | -$17.21 M(-20.1%) | -$4.65 M(+11.0%) | -$17.21 M(-8.7%) |
| Sep 2019 | - | -$4.18 M(+4.1%) | -$18.86 M(+6.3%) |
| Jun 2019 | - | -$4.02 M(-7.8%) | -$17.73 M(-12.3%) |
| Mar 2019 | - | -$4.36 M(-30.7%) | -$20.21 M(-6.2%) |
| Dec 2018 | -$21.54 M(+1.8%) | -$6.29 M(+105.6%) | -$21.54 M(-1.8%) |
| Sep 2018 | - | -$3.06 M(-52.9%) | -$21.94 M(-6.0%) |
| Jun 2018 | - | -$6.50 M(+14.4%) | -$23.34 M(+3.7%) |
| Mar 2018 | - | -$5.68 M(-15.1%) | -$22.51 M(+5.7%) |
| Dec 2017 | -$21.16 M(+32.3%) | -$6.70 M(+50.0%) | -$21.30 M(+263.6%) |
| Sep 2017 | - | -$4.46 M(-21.3%) | -$5.86 M(-25.5%) |
| Jun 2017 | - | -$5.67 M(+26.8%) | -$7.87 M(-31.5%) |
| Mar 2017 | - | -$4.47 M(-151.1%) | -$11.49 M(-28.1%) |
| Dec 2016 | -$15.99 M(-53.3%) | $8.74 M(-235.1%) | -$15.99 M(-50.5%) |
| Sep 2016 | - | -$6.47 M(-30.3%) | -$32.32 M(-6.3%) |
| Jun 2016 | - | -$9.29 M(+3.6%) | -$34.48 M(+0.6%) |
| Mar 2016 | - | -$8.97 M(+18.2%) | -$34.27 M(+0.2%) |
| Dec 2015 | -$34.22 M | -$7.59 M(-12.1%) | -$34.22 M(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$8.63 M(-4.9%) | -$36.32 M(-5.1%) |
| Jun 2015 | - | -$9.08 M(+1.9%) | -$38.26 M(-14.9%) |
| Mar 2015 | - | -$8.91 M(-8.1%) | -$44.95 M(-6.1%) |
| Dec 2014 | -$43.90 M(+54.1%) | -$9.69 M(-8.3%) | -$47.89 M(+6.0%) |
| Sep 2014 | - | -$10.57 M(-33.0%) | -$45.20 M(+8.8%) |
| Jun 2014 | - | -$15.78 M(+33.2%) | -$41.52 M(+23.1%) |
| Mar 2014 | - | -$11.85 M(+69.3%) | -$33.73 M(+18.4%) |
| Dec 2013 | -$28.49 M(+34.4%) | -$7.00 M(+1.5%) | -$28.49 M(+5.2%) |
| Sep 2013 | - | -$6.89 M(-13.7%) | -$27.07 M(+5.3%) |
| Jun 2013 | - | -$7.99 M(+20.8%) | -$25.70 M(+9.8%) |
| Mar 2013 | - | -$6.61 M(+18.5%) | -$23.40 M(+10.4%) |
| Dec 2012 | -$21.20 M(+69.8%) | -$5.58 M(+0.9%) | -$21.20 M(+10.3%) |
| Sep 2012 | - | -$5.53 M(-2.7%) | -$19.21 M(+12.2%) |
| Jun 2012 | - | -$5.68 M(+28.9%) | -$17.12 M(+24.8%) |
| Mar 2012 | - | -$4.41 M(+22.7%) | -$13.72 M(-5.9%) |
| Dec 2011 | -$12.49 M(-24.9%) | -$3.59 M(+4.6%) | -$14.58 M(-0.7%) |
| Sep 2011 | - | -$3.44 M(+50.8%) | -$14.68 M(-1.9%) |
| Jun 2011 | - | -$2.28 M(-56.8%) | -$14.97 M(-14.2%) |
| Mar 2011 | - | -$5.28 M(+42.7%) | -$17.44 M(+4.9%) |
| Dec 2010 | -$16.63 M(-5.1%) | -$3.70 M(-0.6%) | -$16.63 M(-3.5%) |
| Sep 2010 | - | -$3.72 M(-21.8%) | -$17.22 M(-1.5%) |
| Jun 2010 | - | -$4.75 M(+6.7%) | -$17.48 M(-1.8%) |
| Mar 2010 | - | -$4.46 M(+3.8%) | -$17.80 M(+1.6%) |
| Dec 2009 | -$17.52 M(+20.4%) | -$4.29 M(+7.8%) | -$17.52 M(+1.5%) |
| Sep 2009 | - | -$3.98 M(-21.5%) | -$17.26 M(+3.1%) |
| Jun 2009 | - | -$5.08 M(+21.7%) | -$16.74 M(+4.6%) |
| Mar 2009 | - | -$4.17 M(+3.5%) | -$16.01 M(+10.0%) |
| Dec 2008 | -$14.55 M(+27.2%) | -$4.03 M(+16.3%) | -$14.55 M(+9.5%) |
| Sep 2008 | - | -$3.46 M(-20.3%) | -$13.29 M(+4.5%) |
| Jun 2008 | - | -$4.35 M(+60.2%) | -$12.72 M(-4.1%) |
| Mar 2008 | - | -$2.71 M(-2.0%) | -$13.26 M(+10.9%) |
| Dec 2007 | -$11.44 M(+375.6%) | -$2.77 M(-4.3%) | -$11.96 M(+20.1%) |
| Sep 2007 | - | -$2.89 M(-40.9%) | -$9.96 M(+40.9%) |
| Jun 2007 | - | -$4.89 M(+246.5%) | -$7.07 M(+224.6%) |
| Mar 2007 | - | -$1.41 M(+84.3%) | -$2.18 M(+184.3%) |
| Dec 2006 | -$2.40 M | -$766.00 K | -$766.00 K |
FAQ
- What is SELLAS Life Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual EBIT year-on-year change?
- What is SELLAS Life Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly EBIT year-on-year change?
- What is SELLAS Life Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for SELLAS Life Sciences?
- What is SELLAS Life Sciences TTM EBIT year-on-year change?
What is SELLAS Life Sciences annual earnings before interest & taxes?
The current annual EBIT of SLS is -$37.87 M
What is the all time high annual EBIT for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual earnings before interest & taxes is -$2.40 M
What is SELLAS Life Sciences annual EBIT year-on-year change?
Over the past year, SLS annual earnings before interest & taxes has changed by -$5.92 M (-18.53%)
What is SELLAS Life Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of SLS is -$7.33 M
What is the all time high quarterly EBIT for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly earnings before interest & taxes is $8.74 M
What is SELLAS Life Sciences quarterly EBIT year-on-year change?
Over the past year, SLS quarterly earnings before interest & taxes has changed by +$848.00 K (+10.37%)
What is SELLAS Life Sciences TTM earnings before interest & taxes?
The current TTM EBIT of SLS is -$32.77 M
What is the all time high TTM EBIT for SELLAS Life Sciences?
SELLAS Life Sciences all-time high TTM earnings before interest & taxes is -$766.00 K
What is SELLAS Life Sciences TTM EBIT year-on-year change?
Over the past year, SLS TTM earnings before interest & taxes has changed by +$5.10 M (+13.46%)